Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Moxisurge
- Development stage
- Phase 4
- Lead developer
- Micro Labs
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
Moxisurge is an ophthalmic antibiotic solution containing moxifloxacin, a fourth-generation fluoroquinolone. It is indicated for the treatment of bacterial conjunctivitis and other superficial ocular infections caused by susceptible strains of microorganisms. The drug exerts its antibacterial effect by inhibiting the bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV, which are essential for bacterial DNA replication, transcription, repair, and recombination. Moxisurge was introduced to the Indian market through a strategic partnership between Bausch + Lomb and Micro Labs, where Micro Labs provides manufacturing expertise and Bausch + Lomb manages the sales, marketing, and commercialization efforts.
- Brand names
- Moxisurge
- Other names
- moxifloxacin ophthalmic
02
Targets
DNA gyraseTopo IV (Bacterial Topoisomerase IV)
Beyond the preview
Go deeper on Moxisurge.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Moxisurge.